Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.

[1]  W. Braun,et al.  Sequence specificity, statistical potentials, and three‐dimensional structure prediction with self‐correcting distance geometry calculations of β‐sheet formation in proteins , 2008 .

[2]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[3]  K. Hasegawa,et al.  Amyloid Fibril Formation in the Context of Full-length Protein , 2003, Journal of Biological Chemistry.

[4]  W. Strittmatter,et al.  Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila. , 2003, Human molecular genetics.

[5]  D. Dash,et al.  Role of histidine interruption in mitigating the pathological effects of long polyglutamine stretches in SCA1: A molecular approach , 2003, Protein science : a publication of the Protein Society.

[6]  Junying Yuan,et al.  Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders , 2003, Nature.

[7]  R. Wetzel,et al.  Mutational analysis of the structural organization of polyglutamine aggregates , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Fischbeck,et al.  Toxic Proteins in Neurodegenerative Disease , 2002, Science.

[9]  Ronald Wetzel,et al.  Amyloid-like features of polyglutamine aggregates and their assembly kinetics. , 2002, Biochemistry.

[10]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[11]  T. Hashikawa,et al.  Intra- and Intermolecular β-Pleated Sheet Formation in Glutamine-repeat Inserted Myoglobin as a Model for Polyglutamine Diseases* , 2001, The Journal of Biological Chemistry.

[12]  C. Jodice,et al.  Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro , 2001, Brain Research Bulletin.

[13]  C. Ross,et al.  Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases. , 2001, Trends in Molecular Medicine.

[14]  M. F. Perutz,et al.  Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats , 2001, Nature.

[15]  A. Goldberg,et al.  Cellular Defenses against Unfolded Proteins A Cell Biologist Thinks about Neurodegenerative Diseases , 2001, Neuron.

[16]  James F. Gusella,et al.  Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease , 2000, Nature Reviews Neuroscience.

[17]  James R. Burke,et al.  Inhibition of Polyglutamine Protein Aggregation and Cell Death by Novel Peptides Identified by Phage Display Screening* , 2000, The Journal of Biological Chemistry.

[18]  H. Paulson,et al.  Analysis of the Role of Heat Shock Protein (Hsp) Molecular Chaperones in Polyglutamine Disease , 1999, The Journal of Neuroscience.

[19]  C. Ross,et al.  Preparation of human cDNAs encoding expanded polyglutamine repeats , 1999, Neuroscience Letters.

[20]  A. Novelletto,et al.  CAG repeat instability, cryptic sequence variation and pathogeneticity: evidence from different loci. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[21]  Claudio Soto,et al.  β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.

[22]  A. Roses,et al.  Oligomerization of expanded-polyglutamine domain fluorescent fusion proteins in cultured mammalian cells. , 1997, Biochemical and biophysical research communications.

[23]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[24]  C. Soto,et al.  Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. , 1996, Biochemical and biophysical research communications.

[25]  B. Popovich,et al.  A novel CAG repeat configuration in the SCA1 gene: implications for the molecular diagnostics of spinocerebellar ataxia type 1. , 1995, Human molecular genetics.

[26]  Y. Agid,et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.

[27]  M. Hurle,et al.  Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. , 1995, Biochemistry.

[28]  Ponzy Lu,et al.  Prediction of protein structure and principles of protein conformation Edited by G. D. Fasman. New York: Plenum Press. (1989). 798 pp. $95.00 , 1990, Cell.

[29]  H. Zoghbi,et al.  Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.

[30]  J. Richardson,et al.  Principles and Patterns of Protein Conformation , 1989 .